BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2258942)

  • 1. Methylprednisolone in spinal cord injury: the possible mechanism of action.
    Hsu CY; Dimitrijevic MR
    J Neurotrauma; 1990; 7(3):115-9. PubMed ID: 2258942
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain protection by methylprednisolone in rats with spinal cord injury.
    Chang CM; Lee MH; Wang TC; Weng HH; Chung CY; Yang JT
    Neuroreport; 2009 Jul; 20(10):968-72. PubMed ID: 19525878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose methylprednisolone in the treatment of spinal cord injuries.
    Hilton G; Frei J
    Heart Lung; 1991 Nov; 20(6):675-80. PubMed ID: 1960072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of racemic ketamine and (S)-ketamine on spinal cord injury in rat.
    Kose EA; Bakar B; Ayva SK; Kilinc K; Apan A
    Injury; 2012 Jul; 43(7):1124-30. PubMed ID: 22436574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylprednisolone after spinal cord injury.
    Segatore M; Way C
    SCI Nurs; 1993 Mar; 10(1):8-14. PubMed ID: 8484108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single exposure to erythropoietin modulates Nerve Growth Factor expression in the spinal cord following traumatic injury: comparison with methylprednisolone.
    Fumagalli F; Madaschi L; Brenna P; Caffino L; Marfia G; Di Giulio AM; Racagni G; Gorio A
    Eur J Pharmacol; 2008 Jan; 578(1):19-27. PubMed ID: 17936749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury.
    Cayli SR; Kocak A; Yilmaz U; Tekiner A; Erbil M; Ozturk C; Batcioglu K; Yologlu S
    Eur Spine J; 2004 Dec; 13(8):724-32. PubMed ID: 15232723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylprednisolone for spinal cord injury.
    Rosner MJ
    J Neurosurg; 1992 Aug; 77(2):324-5; author reply 325-7. PubMed ID: 1625026
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of methylprednisolone, naloxone, and spinal cord trauma on four liver enzymes: observations from NASCIS 2. National Acute Spinal Cord Injury Study.
    Shepard MJ; Bracken MB
    Paraplegia; 1994 Apr; 32(4):236-45. PubMed ID: 8022633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylprednisolone improves neurologic function after spinal-cord injury, study shows.
    Clin Pharm; 1990 Jul; 9(7):502. PubMed ID: 2376110
    [No Abstract]   [Full Text] [Related]  

  • 11. Methylprednisolone fails to improve functional and histological outcome following spinal cord injury in rats.
    Pereira JE; Costa LM; Cabrita AM; Couto PA; Filipe VM; Magalhães LG; Fornaro M; Di Scipio F; Geuna S; Maurício AC; Varejão AS
    Exp Neurol; 2009 Nov; 220(1):71-81. PubMed ID: 19665461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study.
    Bracken MB; Shepard MJ; Collins WF; Holford TR; Young W; Baskin DS; Eisenberg HM; Flamm E; Leo-Summers L; Maroon J
    N Engl J Med; 1990 May; 322(20):1405-11. PubMed ID: 2278545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy is activated in injured neurons and inhibited by methylprednisolone after experimental spinal cord injury.
    Chen HC; Fong TH; Lee AW; Chiu WT
    Spine (Phila Pa 1976); 2012 Mar; 37(6):470-5. PubMed ID: 21587101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of methylprednisolone and 4-chloro-3-hydroxyanthranilic acid in experimental spinal cord injury in the guinea pig appear to be mediated by different and potentially complementary mechanisms.
    Yates JR; Gay EA; Heyes MP; Blight AR
    Spinal Cord; 2014 Sep; 52(9):662-6. PubMed ID: 25047053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of dexmedetomidine in experimental spinal cord injury compared to methylprednisolone in rats.
    Gul S; Hanci V; Bahadir B; Acikgoz S; Bektas S; Ankarali H; Kalayci M; Acikgoz B
    J Clin Neurosci; 2010 Apr; 17(4):490-4. PubMed ID: 20116256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapeutic window for methylprednisolone treatment of acute spinal cord injury: implications for cell injury mechanisms.
    Young W
    Res Publ Assoc Res Nerv Ment Dis; 1993; 71():191-206. PubMed ID: 8417466
    [No Abstract]   [Full Text] [Related]  

  • 17. High-dose methylprednisolone after acute spinal cord injury.
    Nayduch D; Lee A; Butler D
    Crit Care Nurse; 1994 Aug; 14(4):69-72, 77-8. PubMed ID: 8055691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assessment of neurologic function and complications in a retrospective cohort of patients with acute spinal cord injury due to trauma treated with large-dose methylprednisolone].
    Aomar Millán M; Cortiñas Sáenz M; Delgado Tapia J; Gerónimo Pardo M; Calatayud Pérez V; Peyró García R
    Rev Esp Anestesiol Reanim; 2011 Dec; 58(10):583-8. PubMed ID: 22263402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of megadose methylprednisolone therapy on acute spinal cord injury in rats].
    Imamura H
    Hokkaido Igaku Zasshi; 1994 Mar; 69(2):236-47. PubMed ID: 8157249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological treatment of acute spinal cord injury: current status and future projects.
    Bracken MB
    J Emerg Med; 1993; 11 Suppl 1():43-8. PubMed ID: 8445202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.